Actelion Stock

Stocks

31/07/17	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
19/07/17	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
19/07/17	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
10/06/17	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
10/06/17	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
09/06/17	Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	RE
22/05/17	Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high	RE
18/05/17	Actelion : Johnson & Johnson offers EU concessions over Actelion deal	RE
20/04/17	Actelion : Johnson & Johnson target Actelion could exit Swiss benchmark SMI index this month	RE
18/04/17	Actelion : Johnson & Johnson first quarter revenue misses estimates; new forecast includes Actelion	RE
05/04/17	Actelion : shareholders back R&D spinoff, keep J&J deal on track	RE
31/03/17	Actelion : J&J declares Actelion tender offer a success, sees closing in second quarter	RE
23/02/17	Genmab A/S : and J&J's cancer drug set for blockbuster sales this year	RE

06/04/20	Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	AQ
31/10/17	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	GL
30/06/17	Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	GL
16/06/17	Actelion : Johnson & Johnson Completes Acquisition of Actelion	GL
16/06/17	Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	PU

29/01/18	Après Bioverativ, Sanofi s'empare de la biotech belge Ablynx pour 3,9 mrd EUR
29/01/18	Après Bioverativ, Sanofi rachète la biotech belge Ablynx pour 3,9 mrd EUR
22/01/18	Avec Bioverativ, Sanofi devient un leader mondial dans l'hémophilie
31/10/17	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
30/10/17	Actelion: la décotation est agendée au 7 novembre

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACTELION	-.--%	+0.99%	-	-	0
WUXI APPTEC CO., LTD.	+10.00%	+4.50%	+58.63%	+71.20%	66.87B
LONZA GROUP AG	+1.27%	+4.49%	+24.37%	+102.05%	56.55B
ARGENX SE	+1.50%	+2.83%	+14.35%	+79.13%	57.2B
IQVIA HOLDINGS INC.	+0.46%	-5.47%	+25.04%	+33.77%	43.47B
REVOLUTION MEDICINES, INC.	+2.82%	+5.82%	+240.96%	+801.17%	42.8B
BEONE MEDICINES AG	+6.42%	+1.18%	+22.18%	+105.56%	42.95B
GENMAB A/S	+3.35%	-2.51%	+100.82%	+84.47%	32.11B
CELLTRION, INC.	+5.32%	+5.37%	+19.12%	+52.98%	34.01B
INSMED INCORPORATED	+5.32%	+13.43%	-39.82%	+342.66%	24.13B
Average	+4.17%	+2.73%	+51.74%	+185.89%	44.45B
Weighted average by Cap.	+4.71%	+2.58%	+53.49%	+170.30%